<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We demonstrate here that the Epstein-Barr virus (EBV) BZLF1 gene, a switch from <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> to lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, is expressed as early as 1.5 h after <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived, EBV-negative Akata and Daudi cells and primary B lymphocytes </plain></SENT>
<SENT sid="1" pm="."><plain>Since BZLF1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> is expressed even when the cells are infected with EBV in the presence of anisomycin, an inhibitor of protein synthesis, its expression does not require prerequisite protein synthesis, indicating that BZLF1 is expressed as an immediate-early gene following primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> of B lymphocytes </plain></SENT>
</text></document>